- Report
- April 2025
- 200 Pages
Global
From €7252EUR$7,950USD£6,199GBP
- Report
- August 2020
- 80 Pages
Global
From €2965EUR$3,250USD£2,534GBP
Ganaxolone is a drug used to treat mental disorders, such as anxiety, depression, and post-traumatic stress disorder (PTSD). It is a synthetic form of a naturally occurring neurosteroid, allopregnanolone, which is known to have calming effects on the brain. Ganaxolone is available in both oral and intravenous forms, and is used to treat a variety of mental health conditions.
Ganaxolone is a relatively new drug, and is still in the early stages of development. It is currently being studied in clinical trials for its potential to treat a variety of mental health conditions, including bipolar disorder, schizophrenia, and autism spectrum disorder.
The Ganaxolone market is growing rapidly, as more people are seeking treatment for mental health conditions. The drug is being studied for its potential to provide relief from a variety of mental health conditions, and is being used in clinical trials to assess its efficacy.
Some companies in the Ganaxolone market include Marinus Pharmaceuticals, Inc., Neurocrine Biosciences, Inc., and Sage Therapeutics, Inc. Show Less Read more